Feasibility of Early and Repeated Low-dose Interscalene Brachial Plexus Block for Residual Pain in Acute Cervical Radiculopathy Treated with NSAIDS.
10.3344/kjp.2014.27.2.125
- Author:
Toshio IWATA
1
;
Mari MITORO
;
Naoya KUZUMOTO
Author Information
1. Department of Anesthesiology, Nara Prefectural Mimuro Hospital, Nara, Japan. notkorit4ky@yahoo.co.jp
- Publication Type:Original Article
- Keywords:
acute;
brachial plexus;
cervical radiculopathy;
low-dose;
nerve block
- MeSH:
Anti-Inflammatory Agents, Non-Steroidal*;
Brachial Plexus*;
Humans;
Mepivacaine;
Nerve Block;
Outpatients;
Pain Management;
Patient Satisfaction;
Prospective Studies;
Radiculopathy*;
Ultrasonography
- From:The Korean Journal of Pain
2014;27(2):125-132
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: To improve residual pain management in acute cervical radiculopathy treated with NSAIDs, the feasibility of early and repeated low-dose interscalene brachial plexus block (IS-BPB) needs to be assessed. METHODS: This was a prospective study on patients receiving NSAIDs (loxoprofen) for cervical radiculopathy of < or = 2-week onset. Pain was assessed using the visual analogue scale (VAS). A low-dose ultrasonography (USG)-guided IS-BPB (dexamethasone [1.65 mg; 0.5 ml] and mepivacaine [1%; 3.0 ml]) was performed at baseline and weekly thereafter for 4 weeks in an outpatient setting for the intervention group. All patients were evaluated using a visual satisfaction score (VSS) at week 4. Patients with baseline VAS scores < 70 (mild to moderate pain; MM group) and > or = 70 (severe pain; SE group) were compared to the controls receiving NSAIDs. RESULTS: A total of 316 IS-BPBs were performed in the intervention group. There was a significant difference in the decline in the VAS from week 0 to week 3 in the MM and SE groups (P < 0.05); however, from week 3 to week 4, the therapeutic effect exhibited no significant difference. Thirteen patients at week 2 (15.5%; MM: 27.7%; SE: 0%), 43 at week 3 (51.2%; MM: 83.0%; SE: 10.8%), and 47 at week 4 (56.0%; MM: 85.1%; SE: 18.9%) achieved a VAS score of < or = 20. Patient satisfaction was high, and the decrease in VAS scores in both groups was significant (P < 0.05) compared to the controls. CONCLUSIONS: Weekly, low-dose, USG-guided IS-BPB can be implemented for early pain relief in acute cervical radiculopathy, with high patient satisfaction.
